A new study has revealed that mRNA COVID-19 vaccines may cause severe genetic disruptions, potentially leading to cancer and chronic illness.
The findings were shared by the McCullough Foundation, which described the results as “severe and long-lasting.”
Researchers used high-resolution RNA sequencing to examine blood samples from individuals who developed new-onset adverse events or cancer after vaccination.
They compared those samples to a healthy control group to identify differences in gene expression.
The study found widespread transcriptomic dysregulation in both groups of vaccine recipients.
Participants with nonmalignant reactions showed signs of mitochondrial dysfunction, immune reprogramming, and systemic inflammation.
Those diagnosed with cancer displayed additional markers of genomic instability and epigenetic changes.
Common findings in both groups included MYC activation, ribosomal stress, and nonsense-mediated decay—all associated with oncogenesis.
The research team concluded that these effects suggest persistent cellular stress and immune disruption after mRNA exposure.
The cancer patient group also showed elevated immune signaling through Toll-like receptors and type I interferons.
Lead researcher Dr. Peter McCullough called for immediate public health review of ongoing vaccine recommendations.
He stated that continued administration of mRNA boosters may increase the risk of serious complications in susceptible individuals.
The McCullough Foundation warned that spike protein persistence and immune overactivation could trigger or accelerate disease processes.
Authors of the study included Natalia von Ranke, Wei Zhang, Philipp Anokin, Nicolas Hulscher, Kevin J. McKernan, and John A. Catanzaro.
Their collective analysis used DESeq2 for differential gene expression and GSEA through the MSigDB database.
Researchers emphasized that both affected cohorts showed alterations in thousands of genes lasting for months or longer.
They noted that gene expression changes were not transient but remained active well beyond the injection period.
The study raises concerns about off-target effects in vaccinated individuals, especially those with genetic predispositions.
While not all recipients may experience severe outcomes, the data suggest a clear biological mechanism that warrants caution.
The McCullough Foundation posted its findings on social media, urging immediate withdrawal of mRNA vaccines from public distribution.
Their statement emphasized protecting the unvaccinated 20% of the population still considering booster doses.
These findings challenge prior assumptions about the long-term safety of synthetic mRNA technology in vaccine development.
Researchers called for expanded investigation into host genetic variability and how it influences adverse outcomes.
The team urged independent review of vaccine safety data and more transparent post-market surveillance.
The paper’s conclusion stressed the need for urgent reevaluation of mass mRNA vaccination campaigns.